This pilot project evaluated whether targeted training could strengthen clinical research capacity at community cancer centers, improve readiness to conduct oncology trials, and support more inclusive ...

Baystate Health announces the appointment of Dr. Matthew D. Di Guglielmo, as the new chair of the Department of Pediatrics at ...

Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...

The agency’s budget has grown steadily since the 1960s, fueling an industry that creates lifesaving medicines and attracts ...

THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST END-OF-PHASE 2 (EOP2) ...

President Cunningham’s “All Minnesota” plan, developed in partnership with statewide providers, is the better path.

LR BV100 Phase 3 in Ventilator Associated Bacterial Pneumonia initiated with first country submission completed and first patients to be dosed in the coming months – Phase 3 read-out expected in H2 ...

FINDLAY, OH – December 12, 2025 – PRESSADVANTAGE – Applied Neuroscientist and Communication Strategist Dr. Andrea ...

Maxim Group LLC is acting as the exclusive Financial Advisor for the transaction PHILADELPHIA, PA / ACCESS Newswire / ...

In addition to CG001419, Cullgen continues the advancement of CG009301, a GSPT1 degrader being studied in a Phase 1 trial for the treatment of blood cancers, as well as progressing its pipeline of pre ...

Dengue fever is the leading cause of mosquito-borne viral disease worldwide, with over 100 million cases reported annually.

Earlier in November, Home Healthcare, Hospice & Community Services (HCS) appointed Karen Gomes as its new interim CEO. Gomes ...